title: Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy.
abstract: BACKGROUND
  Gastrointestinal disturbances are important prognostic factors for mortality and morbidity after liver transplantation for familial amyloidotic polyneuropathy (FAP). However, the impact of liver transplantation on malabsorption and bacterial small-bowel contamination has not been evaluated.
  
  
  METHODS
  Twenty-three FAP patients were available for the study. They were examined for gastrointestinal disturbances as a part of the evaluation for liver transplantation for FAP. Bile acid malabsorption was diagnosed with the [75Se]-homocholic acid taurate (SeHCAT) test; fat malabsorption by measuring faecal fat excretion; and bacterial small-bowel contamination with the hydrogen breath test (HBT).
  
  
  RESULTS
  No significant improvement of malabsorption test results were noted from the pre-transplant evaluation 8 months (range, 2-20 months) before transplantation to the post-transplant evaluation performed a median of 20 months (range, 9-62 months) after the procedure. The SeHCAT test result became abnormal in two patients and normal in one, and changes in the test correlated with the time the patients were waiting for transplantation. Faecal fat excretion after transplantation correlated with duration of the disease and with fat excretion before transplantation. A significantly increased fat excretion was noted at the post-transplant evaluation. A change in HBT result was noted in only one patient, in whom the test result became normal; pre-transplant values correlated with those obtained after transplantation.
  
  
  CONCLUSIONS
  For most FAP patients no improvement in gastrointestinal function was found after transplantation. The finding underlines the importance of an early transplantation before the patients have developed gastrointestinal dysfunction.
authors.affiliation: Dept. of Medicine, Piteå Hospital, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Lång
authors.forename: L
authors.initials: L
authors.lastname: Wikström
authors.forename: A
authors.initials: A
authors.lastname: Danielsson
authors.forename: K
authors.initials: K
authors.lastname: Tashima
authors.forename: O B
authors.initials: OB
authors.lastname: Suhr
mesh_terms: D000328:Adult; D017772:Amyloid Neuropathies / Q000150:complications / Q000235:genetics / Q000601:surgery*; D001424:Bacterial Infections / Q000453:epidemiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007421:Intestine, Small / Q000382:microbiology; D016031:Liver Transplantation; D008286:Malabsorption Syndromes / Q000453:epidemiology*; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology*; D013997:Time Factors